Written by Williams ABAH

Scientists to produce anti-cancer drugs in yeast

Nature is so complex that natural molecules used for i.e. cancer treatment still can't be produced by chemical synthesis. Today, major chemical and pharmaceutical companies harvest large amounts of rare plants and seeds in order to extract valuable substances.

But the production methods based on extracts from natural resources are environmentally damaging and often give rise to extensive piles of chemical waste. In addition, there is a great danger that these rare plants will go extinct.

The need to find new and more sustainable production methods for these types of medicines has grown since the UN recently adopted new regulations to protect biodiversity and raw materials in third world countries.

"With these new rules, a real alternative is needed if we wish to be able to produce therapeutics to cancer patients or people suffering from mental illnesses in the future," says Senior Researcher at The Novo Nordisk Foundation Center for Biosustainability. He is the coordinator of a new big EU Horizon 2020 project called MIAMi, which has just received a grant of 6 million Euro.

In many cases, these very complex plant chemicals can't be synthesized chemically like 'normal' pharmaceuticals -- it simply has to be a bio-catalytic process.

The aim of the MIAMi research project is to provide the pharmaceutical industry with an alternative production route using the cellular workhorse baker's yeast. To start with, the researchers want to map the so-called biosynthetic pathways of the rare plant Rauvolfia serpentina with the common name Indian snakeroot.

From traditional Chinese medicine, it is known that Indian snakeroot produces molecules with anticancer effect.

However, manufacturing the valuable compounds outside the plant is still not possible, because the biosynthetic pathways are unknown.

In short, a biosynthetic pathway is a number of specific genes that code for enzymes, which synthesize a bio-molecule within the cell. Knowing the genetic "route" of the product, makes it possible to move the genes into, for instance, baker's yeast.

The goal is to insert the genes into yeast cells that will act as biological cell factories capable of producing large amounts of these specific therapeutic substances.



Latest posts

Photo300,000 Abuja residents vaccinated against polio

No fewer than 300, 000 residents of Galuwyi community, off Mpape, in Bwari Area Council, have been vaccinated against polio infections. 

< [...]

17 August 2019

PhotoAbaji chairman tasks Muslims on good conduct

The chairman of Abaji area council, Alh. Abdulrahman Ajiya, has tasked Muslim faithful to emulate the life style of Prophet Muhammad. 


17 August 2019